<Record>
<Term>Leukocyte Adhesion Deficiency Type 2</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<ParentTerm>Leukocyte Adhesion Deficiency</ParentTerm>
<ClassificationPath>Findings_and_Disorders_Kind/Disease, Disorder or Finding/Disease or Disorder/Syndrome/Immunodeficiency Syndrome/Congenital Disorder of Natural Immunity/Leukocyte Adhesion Deficiency/Leukocyte Adhesion Deficiency Type 2</ClassificationPath>
<BroaderTerm>Leukocyte Adhesion Deficiency</BroaderTerm>
<BroaderTerm>Leukocyte Adhesion Deficiency Type 2</BroaderTerm>
<BroaderTerm>Immunodeficiency Syndrome</BroaderTerm>
<BroaderTerm>Syndrome</BroaderTerm>
<BroaderTerm>Disease or Disorder</BroaderTerm>
<BroaderTerm>Congenital Disorder of Natural Immunity</BroaderTerm>
<BroaderTerm>Disease, Disorder or Finding</BroaderTerm>
<BroaderTerm>Findings_and_Disorders_Kind</BroaderTerm>
<Synonym>LAD-Type II</Synonym>
<Synonym>Leukocyte Adhesion Deficiency Type 2</Synonym>
<Synonym>Sialyl-Lewis X Defect</Synonym>
<Description>Leukocyte Adhesion Deficiency, Type II.  An inherited disease affecting the metabolism of fucose, which affects the expression of the sialyl Lewis X antigen, the fucose-containing ligand for E- and P-selectins, resulting in a deficiency in neutrophil adhesion.  SYN Sialyl-Lewis X defect.</Description>
<Source>NCI Thesaurus</Source>
</Record>
